$52 Million pending via Pharmaceutical Benefit Plan Settlements, separate from the Generic Pharmaceuticals Pricing Antitrust Litigation. Overview There are typically several active lawsuits and/or class action settlements that fall into the category of “pharmaceutical benefit plan settlements.” Under these cases, it is generally alleged that businesses with self-insured health plans overpaid for drugs purchased on behalf of their employees due to artificially inflated and/or

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION Current Settlement Totals: Direct Purchasers (Wholesalers and Distributors):...

Updated: August 2022 IN RE: NATIONAL PRESCRIPTION OPIATE LITIGATION Case Overview Entities in every link in the chain of opioid drug...